Puzo Michael J reduced its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 2.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 69,913 shares of the company's stock after selling 2,005 shares during the quarter. Procter & Gamble makes up approximately 3.2% of Puzo Michael J's investment portfolio, making the stock its 12th biggest position. Puzo Michael J's holdings in Procter & Gamble were worth $11,139,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently bought and sold shares of PG. Nova Wealth Management Inc. purchased a new stake in Procter & Gamble in the 1st quarter worth $26,000. Signature Resources Capital Management LLC increased its stake in Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock worth $28,000 after buying an additional 72 shares in the last quarter. Quarry LP purchased a new stake in Procter & Gamble in the 1st quarter worth $33,000. Mizuho Securities Co. Ltd. increased its stake in Procter & Gamble by 566.7% in the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock worth $34,000 after buying an additional 170 shares in the last quarter. Finally, RMG Wealth Management LLC purchased a new stake in Procter & Gamble in the 2nd quarter worth $37,000. 65.77% of the stock is owned by institutional investors.
Procter & Gamble Trading Up 1.5%
PG opened at $152.60 on Wednesday. The firm has a market cap of $357.16 billion, a P/E ratio of 23.44, a P/E/G ratio of 4.13 and a beta of 0.36. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The stock has a 50-day moving average of $155.30 and a 200 day moving average of $159.79.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm's revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the business posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, research analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.
Analysts Set New Price Targets
A number of brokerages have issued reports on PG. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Weiss Ratings restated a "hold (c+)" rating on shares of Procter & Gamble in a research report on Saturday, September 27th. Wells Fargo & Company cut their price objective on Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating for the company in a research report on Thursday, September 25th. Barclays cut their price objective on Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating for the company in a research report on Wednesday, October 1st. Finally, Berenberg Bank raised their price objective on Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a research report on Wednesday, September 17th. Eleven equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, Procter & Gamble has an average rating of "Moderate Buy" and a consensus price target of $173.11.
Get Our Latest Report on Procter & Gamble
Insider Buying and Selling
In related news, CEO Jon R. Moeller sold 40,119 shares of Procter & Gamble stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $6,309,515.13. Following the completion of the transaction, the chief executive officer owned 319,375 shares in the company, valued at approximately $50,228,106.25. This trade represents a 11.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Gary A. Coombe sold 10,194 shares of Procter & Gamble stock in a transaction dated Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares of the company's stock, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock valued at $23,421,279 in the last quarter. 0.20% of the stock is currently owned by insiders.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.